Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06194838 · ClinicalTrials.gov registry record · NA
Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees
A NA study of Amputation and Prosthesis User, sponsored by Liberating Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT06194838: Recruiting NA study of Amputation and Prosthesis User, sponsored by Liberating Technologies.
NCT06194838 is a NA study of Amputation and Prosthesis User that is actively recruiting participants, run by Liberating Technologies. The registered enrollment target is 26 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06194838, a NA study of Amputation and Prosthesis User, is actively recruiting participants, sponsored by Liberating Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposed project is to gather community-based data from the K2-level Transfemoral Amputee (TFA) population to aid in evidence-based prescription of powered prosthetic knees (i.e., choosing the right device to maximize the benefit for each patient). The investigators intend to use this trial data along with a concurrent study being conducted within the K3-K4 level population to guide the implementation of effective prescriptions towards those that can benefit most from a given device and limit prescription to those who would not see benefit in order to ensure the most judicious use of Department of Defense (DoD) and Veteran's Affairs healthcare dollars. The findings will also be shared with the research community to help drive the design of future devices by identifying what features and functions are most beneficial to which patient populations when the devices are used outside of the laboratory. In summary, more community-based data on how powered prosthetic knees compare with the current standard in TFA populations is needed to allow for improved clinical decision making and clinical outcomes.
Primary Outcome
Prior to each condition, each subject will be fit and aligned on the designated knee by a trained certified prosthetist. An activity monitor (such as the GeneActiv™) will be worn by the subject during each 3 month intervention period. Similar to prior studies, the investigators will use the activity monitor to track the number of steps the subjects take in each condition. A higher step count is a better outcome.
Conditions Studied
Interventions
- DEVICE Ossur Power Knee
- DEVICE Reboocon Intuy Knee
Study Locations (1)
Texas
- Hanger Clinic - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-09-12 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT06194838 shows while recruiting
NCT06194838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (80% lower).
The record links to 6 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Ossur Power Knee is the first listed.
NCT06194838 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06194838 about?
NCT06194838 is a clinical study titled "Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees". The goal of this proposed project is to gather community-based data from the K2-level Transfemoral Amputee (TFA) population to aid in evidence-based prescription of powered prosthetic knees (i.e., choosing the right device to maximize the benefit for each patient). The investigators intend to use th...
What is the current status of trial NCT06194838?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2023-09-12. Estimated completion is 2026-08-31.
What conditions does trial NCT06194838 study?
This clinical trial studies the following conditions: Amputation, Prosthesis User, Lower Limb Amputation Above Knee (Injury), Amputation; Traumatic, Leg, Lower, Limb; Absence, Congenital, Lower.
What interventions are being tested in trial NCT06194838?
The interventions under investigation include: Ossur Power Knee (DEVICE), Reboocon Intuy Knee (DEVICE).
Who is sponsoring clinical trial NCT06194838?
This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06194838 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06194838's enrollment target sits among peer trials
26 30th of 65 higher than 35 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
- NCT04913064 · 26 participants · NA
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI